Are Hospitals Ready for Alzheimer’s Treatment Approval?
HIT Consultant
MARCH 19, 2023
John Showalter, MD, Chief Product Officer at Linus Health The FDA’s recent accelerated approval of Leqembi was welcome news across the Alzheimer’s community. It is expected to be more than six times the size of the public health campaign for COVID-19. billion marketing the medication.
Let's personalize your content